Increased N-linked glycosylation leading to oversialylation of monomeric immunoglobulin A1 from patients with Sjogren's syndrome

被引:0
|
作者
Basset, C
Durand, V
Jamin, C
Clément, JF
Pennec, YL
Youinou, P
Dueymes, M
Roitt, IM
机构
[1] Brest Univ, Sch Med, Dept Internal Med, F-29609 Brest, France
[2] Brest Univ, Sch Med, Inst Synergie Sci & Sante I3S, F-29609 Brest, France
[3] Brest Univ, Sch Med, Immunol Lab, F-29609 Brest, France
[4] UCL, Sch Med, London W1N 8AA, England
[5] Royal Free Hosp, London NW3 2QG, England
关键词
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Increased serum immunoglobulin A (IgA) level is a common finding in primary Sjogren's syndrome (pSS). IgA might not be properly eliminated because of an abnormal glycosylation. We reported previously that IgA(1) from patients with pSS was oversialylated. We extend this finding by showing that monomeric IgA(1) contains more sialic acid (SA) in patients than in controls, as determined by enzyme-linked immunosorbent assay (ELISA) and Western blot with Sambucus nigra agglutinin (SNA), a lectin specific for SA. To localize this excess of SA on the N- and/or O-linked oligosaccharides, we analysed them separately, using N- and O-linked oligosaccharide profiling kits based on fluorophore-assisted carbohydrate electophoresis. N-linked, but not O-linked, oligosaccharides of patients' IgA(1) were oversialylated, and this seemed to be linked to an excess of SA on the same number of polysaccharides as normal IgA(1). To localize the abnormality to the Fab and/or Fc fragments, monomeric IgA(1) was digested with protease, separated and transferred to nitrocellulose, where SA was identified by SNA. Both Fab and Fc fragments appeared to be oversialylated. Oversialylation of N-linked oligosaccharides of IgA(1) from patients with pSS might prevent the recognition of IgA by receptors that are responsible for their clearance, resulting in an excess of serum IgA and related immune complexes.
引用
收藏
页码:300 / 306
页数:7
相关论文
共 50 条
  • [1] Evidence for a site-specific fucosylation of N-linked oligosaccharide of immunoglobulin A1 from normal human serum
    Tanaka, A
    Iwase, H
    Hiki, Y
    Kokubo, T
    Ishii-Karakasa, I
    Toma, K
    Kobayashi, Y
    Hotta, K
    [J]. GLYCOCONJUGATE JOURNAL, 1998, 15 (10) : 995 - 1000
  • [2] Evidence for a site-specific fucosylation of N-linked oligosaccharide of immunoglobulin A1 from normal human serum
    Atsushi Tanaka
    Hitoo Iwase
    Yoshiyuki Hiki
    Tohru Kokubo
    Ikuko Ishii-Karakasa
    Kazunori Toma
    Yutaka Kobayashi
    Kyoko Hotta
    [J]. Glycoconjugate Journal, 1998, 15 : 995 - 1000
  • [3] Posttranslational regulation of CALHM1/3 channel: N-linked glycosylation and S-palmitoylation
    Okui, Motoki
    Murakami, Tatsuro
    Sun, Hongxin
    Ikeshita, Chiaki
    Kanamura, Narisato
    Taruno, Akiyuki
    [J]. FASEB JOURNAL, 2021, 35 (05):
  • [4] B-Cell Clonal Expansions in Parotid Glands of Sjogren's Patients Are Associated with Increased Numbers of N-Glycosylation Motifs in the Immunoglobulin Heavy Chain Genes
    Visser, Annie
    Doorenspleet, Marieke E.
    de Vries, Niek
    Spijkervet, Fred K. L.
    Vissink, Arjan
    Bootsma, Hendrika
    Kroese, Frans G. M.
    Bos, Nicolaas A.
    [J]. ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [5] Somatically introduced N-glycosylation of immunoglobulin - a potential non-specific mechanism for B cell activation in Sjogren's syndrome
    Koelsch, Kristi A.
    Cavett, Joshua
    Smith, Kenneth
    Moore, Jacen S.
    Lehoux, Sylvain D.
    Jia, Nan
    Mather, Tim
    Quadri, Syed M. S.
    Rasmussen, Astrid
    Kaufman, C. Erick
    Lewis, David M.
    Radfar, Lida
    Lessard, Christopher J.
    Kurien, Biji T.
    Cummings, Richard D.
    James, Judith A.
    Sivils, Kathy L.
    Farris, A. Darise
    Scofield, R. Hal
    [J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2018, 36 (03) : S302 - S302
  • [6] Navigating PRKCSH's impact on cancer: from N-linked glycosylation to death pathway and anti-tumor immunity
    Cressey, Ratchada
    Han, Moe Thi Thi
    Khaodee, Worapong
    Xiyuan, Guo
    Qing, Yuan
    [J]. FRONTIERS IN ONCOLOGY, 2024, 14
  • [7] THE ROLE OF IGG N-LINKED SIALYLATION AND GALACTOSYLATION IN PRIMARY SJOGREN'S SYNDROME IN ITS POTENTIAL AS A MARKER OF DISEASE STATE AND DISEASE ACTIVITY
    Achten, H.
    Deroo, L.
    De Boeck, K.
    Jarlborg, M.
    Decruy, T.
    Deprez, J.
    Dumas, E.
    Elewaut, D.
    Peene, I.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 703 - 704
  • [8] N-linked glycosylation is required for C1 inhibitor-mediated protection from endotoxin shock in mice
    Liu, DX
    Gu, XG
    Scafidi, J
    Davis, AE
    [J]. INFECTION AND IMMUNITY, 2004, 72 (04) : 1946 - 1955
  • [9] Elimination of N-linked glycosylation sites from the human IgA1 constant region - Effects on structure and function
    Chuang, PD
    Morrison, SL
    [J]. JOURNAL OF IMMUNOLOGY, 1997, 158 (02): : 724 - 732
  • [10] Immunoglobulin N-Glycosylation Acquired By Somatic Hypermutation As a Potential Mechanism for Non-Specific B Cell Activation in Sjogren's Syndrome
    Koelsch, Kristi A.
    Cavett, Joshua
    Maier-Moore, Jacen
    Smith, Kenneth
    Lessard, Christopher
    Radfar, Lida
    Lewis, David M.
    Kurien, Biji T.
    Rasmussen, Astrid
    Sivils, Kathy
    James, Judith A.
    Farris, A. Darise
    Scofield, R. Hal
    [J]. ARTHRITIS & RHEUMATOLOGY, 2016, 68